Cargando…
The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease: A cross-sectional study
Our aim in this study was to determine soluble tumor necrosis factor (TNF)-like weak inducer of apoptosis (sTWEAK) and interleukin-17A (IL-17A) levels in celiac disease, and their association with the gluten diet and autoantibodies. Eighty patients with celiac diagnosis and 80 healthy control indivi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937905/ https://www.ncbi.nlm.nih.gov/pubmed/27367991 http://dx.doi.org/10.1097/MD.0000000000003937 |
_version_ | 1782441788990029824 |
---|---|
author | Yuksel, Mahmut Kaplan, Mustafa Ates, Ihsan Kilic, Zeki Mesut Yalın Kilic, Hasan Suna, Nuretdin Ates, Hale Kayacetin, Ertugrul |
author_facet | Yuksel, Mahmut Kaplan, Mustafa Ates, Ihsan Kilic, Zeki Mesut Yalın Kilic, Hasan Suna, Nuretdin Ates, Hale Kayacetin, Ertugrul |
author_sort | Yuksel, Mahmut |
collection | PubMed |
description | Our aim in this study was to determine soluble tumor necrosis factor (TNF)-like weak inducer of apoptosis (sTWEAK) and interleukin-17A (IL-17A) levels in celiac disease, and their association with the gluten diet and autoantibodies. Eighty patients with celiac diagnosis and 80 healthy control individuals with similar age, gender and body mass index to the patient group were included in the study. Serum sTWEAK and IL-17A levels were measured by the serum enzyme-linked immunosorbent assay kit. The median IL-17A (117.5 pg/mL vs. 56.7 pg/mL; P = 0.001) level in celiac patients was higher than in the control group, while the median sTWEAK (543 pg/mL vs. 643 pg/mL; P = 0.016) level in patients was determined to be lower. In the patient group, patients who complied with the gluten diet had a lower level of median IL-17A (98.1 pg/mL vs. 197.5 pg/mL; P = 0.034) and a higher level of sTWEAK (606 pg/mL vs. 522.8 pg/mL; P = 0.031) than those who did not adhere. Furthermore, the IL-17A level was higher and the sTWEAK level was lower in celiac patients with positive antibody than those with negative antibody. A positive correlation was determined among anti-gliadin antibody IgA, anti-gliadin antibody IgG, anti-tissue transglutaminase IgG levels and the IL-17A level, and a negative correlation was determined with the sTWEAK level. In celiac disease, the sTWEAK and IL-17A levels differ between patients who cannot adapt to the gluten diet and who are autoantibody positive, and patients who adapt to the diet and are autoantibody negative. We believe that sTWEAK and IL-17A are associated with the inflammation in celiac pathogenesis. |
format | Online Article Text |
id | pubmed-4937905 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-49379052016-08-18 The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease: A cross-sectional study Yuksel, Mahmut Kaplan, Mustafa Ates, Ihsan Kilic, Zeki Mesut Yalın Kilic, Hasan Suna, Nuretdin Ates, Hale Kayacetin, Ertugrul Medicine (Baltimore) 4500 Our aim in this study was to determine soluble tumor necrosis factor (TNF)-like weak inducer of apoptosis (sTWEAK) and interleukin-17A (IL-17A) levels in celiac disease, and their association with the gluten diet and autoantibodies. Eighty patients with celiac diagnosis and 80 healthy control individuals with similar age, gender and body mass index to the patient group were included in the study. Serum sTWEAK and IL-17A levels were measured by the serum enzyme-linked immunosorbent assay kit. The median IL-17A (117.5 pg/mL vs. 56.7 pg/mL; P = 0.001) level in celiac patients was higher than in the control group, while the median sTWEAK (543 pg/mL vs. 643 pg/mL; P = 0.016) level in patients was determined to be lower. In the patient group, patients who complied with the gluten diet had a lower level of median IL-17A (98.1 pg/mL vs. 197.5 pg/mL; P = 0.034) and a higher level of sTWEAK (606 pg/mL vs. 522.8 pg/mL; P = 0.031) than those who did not adhere. Furthermore, the IL-17A level was higher and the sTWEAK level was lower in celiac patients with positive antibody than those with negative antibody. A positive correlation was determined among anti-gliadin antibody IgA, anti-gliadin antibody IgG, anti-tissue transglutaminase IgG levels and the IL-17A level, and a negative correlation was determined with the sTWEAK level. In celiac disease, the sTWEAK and IL-17A levels differ between patients who cannot adapt to the gluten diet and who are autoantibody positive, and patients who adapt to the diet and are autoantibody negative. We believe that sTWEAK and IL-17A are associated with the inflammation in celiac pathogenesis. Wolters Kluwer Health 2016-07-01 /pmc/articles/PMC4937905/ /pubmed/27367991 http://dx.doi.org/10.1097/MD.0000000000003937 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 4500 Yuksel, Mahmut Kaplan, Mustafa Ates, Ihsan Kilic, Zeki Mesut Yalın Kilic, Hasan Suna, Nuretdin Ates, Hale Kayacetin, Ertugrul The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease: A cross-sectional study |
title | The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease: A cross-sectional study |
title_full | The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease: A cross-sectional study |
title_fullStr | The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease: A cross-sectional study |
title_full_unstemmed | The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease: A cross-sectional study |
title_short | The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease: A cross-sectional study |
title_sort | role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17a in the etiopathogenesis of celiac disease: a cross-sectional study |
topic | 4500 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937905/ https://www.ncbi.nlm.nih.gov/pubmed/27367991 http://dx.doi.org/10.1097/MD.0000000000003937 |
work_keys_str_mv | AT yukselmahmut theroleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy AT kaplanmustafa theroleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy AT atesihsan theroleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy AT kiliczekimesutyalın theroleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy AT kilichasan theroleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy AT sunanuretdin theroleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy AT ateshale theroleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy AT kayacetinertugrul theroleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy AT yukselmahmut roleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy AT kaplanmustafa roleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy AT atesihsan roleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy AT kiliczekimesutyalın roleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy AT kilichasan roleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy AT sunanuretdin roleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy AT ateshale roleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy AT kayacetinertugrul roleofsolubletumornecrosisfactorlikeweakinducerofapoptosisandinterleukin17aintheetiopathogenesisofceliacdiseaseacrosssectionalstudy |